期刊文献+

呼吸系统感染高毒力肺炎克雷伯菌的分子基因特点 被引量:7

Molecular gene characteristics of highly virulent Klebsiella pneumoniae in patients with respiratory system infection
原文传递
导出
摘要 目的探究呼吸系统感染高毒力肺炎克雷伯菌的分子基因分布特点和患者临床特征。方法选取2017年9月-2018年10月于焦作市人民医院接受治疗的524例肺炎克雷伯菌呼吸系统感染患者为研究对象,其中148例高毒力肺炎克雷伯菌感染患者为观察组,376例普通肺炎克雷伯菌感染患者为对照组。分析两组患者年龄、性别、基础疾病等临床特征;比较两组毒力质粒pLVPK基因中质粒特有序列(rep)、促荚膜合成因子(rmpA)以及铁载体Aerobactin(iuc)等分子基因的分布特征;比较两组患者生活质量评分;比较高毒力肺炎克雷伯菌和普通肺炎克雷伯菌对不同抗菌药物的耐药性。结果两组患者年龄、性别、临床来源、基础疾病、住院天数、痰培养混合菌比较无差异;两组患者最高体温以及胸部CT检查结果比较差异有统计学意义(P<0.05)。分子基因分布特点比较发现,观察组患者rep、rmpA以及iuc阳性率分别为89.86%(133)、79.73%(118)、91.89%(136),均高于对照组(P<0.05)。观察组患者生活质量总分(83.24±12.27)分,低于对照组患者的(115.59±27.04)分,两组比较差异有统计学意义(P<0.05)。高毒力肺炎克雷伯菌和普通肺炎克雷伯菌对氨苄西林耐药性最高,分别为90.54%和97.60%。结论高毒力肺炎克雷伯菌呼吸系统感染患者生活质量水平较低,高毒力肺炎克雷伯菌毒力质粒pLVPK基因阳性率高于普通肺炎克雷伯菌。 OBJECTIVE To explore the molecular gene characteristics of highly virulent Klebsiella pneumoniae in patients with respiratory system infection and observe the clinical characteristics. METHODS A total of 524 patients with K. pneumoniae respiratory system infection who were treated in Jiaozuo People′s Hospital from Sep 2017 to Oct 2018 were recruited as the study objects, 148 patients who had highly virulent K. pneumoniae infection were assigned as the observation group, and 376 patients who had common K. pneumoniae infection were set as the control group.The clinical characteristics of the two groups of patients such as age, gender and underlying diseases were analyzed, the distribution characteristics of the molecular genes such as plasmid specific sequence(rep), Pod synthesis factor(rmpA) and iron carrier aerobactin(iuc) were observed and compared between the two groups;the score of quality of life was compared between the two groups of patients, and the drug resistance rates were compared between the highly virulent K. pneumoniae strains and the common K. pneumoniae strains. RESULTS There were no significant differences in the age, gender, clinical sources, underlying diseases, hospitalization duration and mixed bacteria cultured from sputum between the two groups of patients.There were significant differences in the highest body temperature and result of chest CT examination between the two groups of patients(P<0.05).As compared with the distribution characteristics of the molecular genes, the positive rates of rep, rmpA and iuc of the observation group were respectively 89.86%(133), 79.73%(118) and 91.89%(136), significantly higher than those of the control group(P<0.05).The total score of quality of life of the observation group was(83.24±12.27) points, significantly lower than(115.59±27.04)points of the control group(P<0.05).The drug resistance rate of the highly virulent K. pneumoniae strains to ampicillin was 90.54%, the common K. pneumoniae strains 97.60%. CONCLUSION The quality of life of the patients with highly virulent K. pneumoniae respiratory system infection is poor, and the positive rate of virulence plasmid pLVPK gene of the highly virulent K. pneumoniae strains is higher than that of the common K. pneumoniae strains.
作者 陈苗 李玉 张洁 陈思 张阳 CHEN Miao;LI Yu;ZHANG Jie;CHEN Si;ZHANG Yang(Jiaozuo People′s Hospital,Jiaozuo,Henan 454000,China)
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2020年第1期6-9,共4页 Chinese Journal of Nosocomiology
基金 焦作市科研计划基金资助项目(728823)。
关键词 高毒力肺炎克雷伯菌 呼吸系统感染 分子基因 耐药性 Highly virulent Klebsiella pneumoniae Respiratory tract infection Molecular gene Drug resistance
  • 相关文献

参考文献5

二级参考文献46

  • 1施德仕,邵海枫.细菌生物膜感染的研究进展[J].医学研究生学报,2011,24(12):1319-1323. 被引量:19
  • 2Schwaber M J, Klarfeld-Lidji S, Navon-Venezia S, et al. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality [ J]. Antimicrob Agents Chemother, 2008,52 (3) : 1028- 1033.
  • 3( CDC ) CfDCaP. Vital signs : carbapenem-resistant Enterobaeteriaceae[ J]. MMWR Morb Mortal Wkly Rep, 2013,62 (9) :165-170.
  • 4Bratu S, Landman D, Haag R, et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium[ J]. Arch Intern Med, 2005,165 (12) : 1430-1435.
  • 5Maltezou HC, Kontopidou F, Katerelos P, et al. Infections caused by carbapenem-resistant Gram-negative pathogens in hospitalized children[ J ]. Pediatr Infect Dis J, 2013,32 (4) : e151-e154. DOI: 10. 1097/INF. 0b013e3182804b49.
  • 6Hsu AJ, Tamma PD. Treatment of multidrug-resistant Gram- negative infections in children [ J ]. Clin Infect Dis , 2014,58 (10) :1439-1448. DOI: 10. 1093/cid/ciu069.
  • 7Logan LK. Carbapenem-resistant enterobacteriaceae: an emerging problem in children[ J]. Clin Infect Dis, 2012,55 (6) :852-859. DOI: 10. 1093/cid/cis543 .
  • 8Dirajlal-Fargo S, DeBiasi R, Campos J, et al. Carbapenem- resistant Enterobacteriaceae in pediatric patients: epidemiology and risk factors [ J]. Infect Control Hosp Epidemiol, 2014,35 (4) :447-449. DOI: 10. 1086/675593.
  • 9Diaz A, Ortiz DC, Trujillo M, et al. Clinical characteristics of carbapenem resistant Klebsiella pneumoniae infections in III and colonized children in Colombia[J]. Pediatr Infect Dis J, 2015 , 12 (10) :447-449. DOI : 10. 1097/INF.
  • 10McKenna M. Antibiotic resistance: the last resort [ J]. Nature, 2013,499 ( 7459 ) : 394-396.

共引文献71

同被引文献58

引证文献7

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部